- Breast
- Lung
- Hematologic Oncology
- Gastrointestinal
- Genitourinary
- General Oncology
- Sarcoma
- Skin
- Head & Neck
- Event
Playback speed
10 seconds
2019 SOHO Updates on CML: Frontline Therapy is Good, Getting Better and Safer, 2nd Line Options Grossly Equivalent, 3rd Line Ponatinib is Better, Complete Cytogenetic Response Improves Survival
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Elias Jabbour
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Elias Jabbour
152 views
December 13, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology